H.C. Wainwright Maintains Kezar Life Sciences(KZR.US) With Hold Rating
Kezar Life Sciences Is Maintained at Equal-Weight by Wells Fargo
Kezar Life Sciences Analyst Ratings
Wells Fargo Maintains Kezar Life Sciences(KZR.US) With Hold Rating, Cuts Target Price to $11
TD Cowen Maintains Kezar Life Sciences(KZR.US) With Buy Rating
Kezar Life Sciences (KZR) Receives a Buy From TD Cowen
Kezar Life Sciences Analyst Ratings
H.C. Wainwright Maintains Kezar Life Sciences(KZR.US) With Hold Rating
H.C. Wainwright Sticks to Its Hold Rating for Kezar Life Sciences (KZR)
H.C. Wainwright Maintains Kezar Life Sciences(KZR.US) With Hold Rating
Kezar Life Sciences Analyst Ratings
Hold Rating on Kezar Life Sciences Amidst Acquisition Proposal and Drug Development Uncertainties
H.C. Wainwright Downgrades Kezar Life Sciences(KZR.US) to Hold Rating
Kezar Life Sciences Analyst Ratings
TD Cowen Maintains Kezar Life Sciences(KZR.US) With Buy Rating
TD Cowen Remains a Buy on Kezar Life Sciences (KZR)
Wells Fargo Maintains Kezar Life Sciences(KZR.US) With Hold Rating, Maintains Target Price $2
Maintaining Hold on Kezar Life Sciences Amid Safety Concerns and Financial Valuation
JonesTrading Maintains Kezar Life Sciences(KZR.US) With Hold Rating
Wells Fargo Maintains Kezar Life Sciences(KZR.US) With Hold Rating, Maintains Target Price $2